Li Lin
1095 Jiefang Avenue, 430030
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Macrophage-derived S100A9 promotes diabetic cardiomyopathy by disturbing mitochondrial quality control via STAT3 activation.
Journal: International journal of biological sciences
Published: January 26, 2025
ACAA2 Protects Against Cardiac Dysfunction and Lipid Peroxidation in Renal Insufficiency with the Treatment of S-Nitroso-L-Cysteine.
Journal: Biomolecules
Published: January 14, 2025
Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases.
Journal: Archives of pharmacal research
Published: December 28, 2023
Effective substances and molecular mechanisms guided by network pharmacology: An example study of Scrophulariae Radix treatment of hyperthyroidism and thyroid hormone-induced liver and kidney injuries.
Journal: Journal of ethnopharmacology
Published: October 16, 2023
Ruxolitinib ameliorated coxsackievirus B3-induced acute viral myocarditis by suppressing the JAK-STAT pathway.
Journal: International immunopharmacology
Published: February 10, 2023
STAT3 signaling promotes cardiac injury by upregulating NCOA4-mediated ferritinophagy and ferroptosis in high-fat-diet fed mice.
Journal: Free radical biology & medicine
Published: December 21, 2022
ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
Journal: International journal of molecular sciences
Published: November 29, 2022
Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice.
Journal: Frontiers in endocrinology
Published: August 04, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience.
Journal: Frontiers in immunology
Published: October 27, 2020
Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
Journal: European journal of pharmacology
Published: August 06, 2020
Last Updated: 09/26/2026